GCF levels of human beta defensins 1and 3 in diabetic and non diabetic patients with chronic periodontitis

Himani Sharma; Harinath Parathasarathy; Deepa Ponnaiyan; Anupama Tadepalli; Gayathri Kumar; Paras Varma

doi:10.53730/ijhs.v6nS1.8698

Authors

Himani Sharma Senior lecturer, Department of Periodontics, IDST Dental College Kadrabad, Modinagar, Ghaziabad, Uttar Pradesh , India 201204
Harinath Parathasarathy Professor, Department of Periodontics, SRM Dental college, Bharathi Salai, Ramapuram, Chennai 600089,Tamilnadu, India
Deepa Ponnaiyan Professor, Department of Periodontics, SRM Dental college, Bharathi Salai, Ramapuram, Chennai 600089, Tamilnadu, India
Anupama Tadepalli Professor, Department of Periodontics, SRM Dental college, Bharathi Salai, Ramapuram, Chennai 600089, Tamilnadu, India
Gayathri Kumar Senior Lecturer, Department of Periodontics, SRM Kattankulathur Dental college, SRM Nagar, Kattankulathur, Chengalpattu District, Tamil Nadu- 603203
Paras Varma Senior lecturer, IDST Dental College Kadrabad, Modinagar, Ghaziabad, Uttar Pradesh, India 201204

Keywords:

HβD-1&3, Periodontitis, type 2 diabetes mellitus, HbA1c, gingival crevicular fluid

Abstract

Background: Human beta defensins (HβDs) expression in healthy tissues may aid in preventing the onset and/or progression of inflammatory disease.Type 2 diabetes mellitus (type 2 DM) and periodontal disease encompass inflammatory changes. HβDs in periodontitis patients is differentially regulated by periodontal pathogens, commensal organisms, host derived factors and inflammatory mediators. Additionally hyperglycaemia might influence this inflammatory state. Aim: To evaluate the role of the expression of human beta-defensin 1 and 3 levels in gingival crevicular fluid samples of gingivitis and chronic periodontitis patients with various glycaemic status. Methods and Material: In this study a total number of 140 patients were divided into five groups (Group I-V) consisted of 28 patients under each group. Group I consisted of 28 Type 2 Diabetes mellitus (DM) patients with well controlled glycemic status (> 6.5 <7%HbA_1C) and chronic periodontitis(CP),Group II compromised of 28 type 2 DM-CP patients(7-8% HbA_1C),Group III had 28 Type 2 DM-CP patients (>8%HbA_1C).The concentrations of HβD-1 and HβD-3 were estimated using ELISA. Results: HβD-1 and 3 levels are higher in gingivitis subjects than periodontitis. Significantly higher levels of HβD-3 expression were found in the healthy tissues compared to the diseased ones.

Downloads

Download data is not yet available.

References

Pollanen M, Salonen JI, and Uitto V J. Structure and function of the tooth-epithelial interface in health and disease. Periodontology 2000 2003; 31(1):12–31.

Dale B A. Periodontal epithelium: A newly recognized role in health and disease,” Periodontology 2000 2002; 30(1):70– 78.

RaoMVRamoji, Preethi, P Lakshmi, M Sathish, P Madhusudhan. Gingival Epithelial Cell Responses to Microbial Infections. Journal of advanced dental Research 2014; 3(2):53-56.

Weinberg Szklarek, Krisanaprakornkit S, and Dale B A. Epithelial antimicrobial peptides: review and significance for oral applications. Critical Reviews in Oral Biology and Medicine1998; 9(4): 399–414.

Toke O. Antimicrobial Peptides: New Candidates in the Fight against Bacterial Infections .Peptide Science 2005; 80: 717–735.

Lehrer R, Ganz T, Selsted M. Defesins: endogenous antibiotic peptides of animal cells. Cell 1991; 64:229–230.

Dale BA, Kimball JR, Krisanaprakornkit S, Roberts F, Robinovitch M, O’Neal R, Valore EV,Ganz T, Anderson GM, Weiberg A. Localized antimicrobial peptide expression in human gingival Journal of Periodontal Research2001; 35:1–10.

Yoshihiro Abiko, MastoSaitoh, Michiko Nishimura Mami Yamazaki, Daisuke Sawamura,TohruKaku.Role of b-defensins in oral epithelial health and disease. Medical Molecular Morphology 2007; 40:179–184.

Harder J, Meyer-Hoffert U, Wehkamp K, Schwichtenberg L, Schröder JM. Differential gene induction of human betadefensins (HβD-1, -2, -3 and -4) in keratinocytes is inhibited by retinoic acid. Journal of Investive Dermatology 2004; 123:522–529.

Vardar-Sengul S, Demirci T, Sen BH, Erkizan V, Kurulgan E, Baylas H. Human b defensin-1 and -2 expression in the gingiva of patients with specific periodontal diseases. Journal of periodontal research 2007; 42: 429–437.

Joly S, Maze C, McCray PB Jr, Guthmiller JM. Human betadefensins 2 and 3 demonstrate strain-selective activity against oral microorganisms. Journal of Clinical Microbiology 2004; 42: 1024–1029

Nicole M.Differential Induction of Human Beta-Defensin Expression by Periodontal Commensals and Pathogens in Periodontal Pocket Epithelial Cells Journal of Periodontology2005; 76(8):1293-1303.

Dunsche Anton, Açil1 Yahya, DommischHenrik, SieberT Reiner, SchröderJens-M. andJepsen Søren.The novel human beta-defensin-3 is widely expressed in oral tissues. European Journal of Oral Science 2000; 110: 121–124.

Sophie Joly, Connie Maze, Paul B., Cray MC, JR., and Janet M. Guthmiller.Strain-selective activity against oral human b-defensins 2 and 3 demonstrate microorganisms. Journal of clinical microbiology 2004 ; (5): 1024–1029

Vankeerberghen Anne, Nuytten Hilde, Dierickx Kurt, Quirynen Marc, Jacques Cassiman Jean, and Cuppens Harry. Differential Induction of Human Beta Defensin Expression by Periodontal Commensals and Pathogens in Periodontal Pocket Epithelial Cells2005. Journal of Periodontology; 76:1293-1303

SamaranayakeLakshman P, Richard P. Darveauand LijianJin. Expression of human β-defensin-3 in gingival epithelia. Journal of Periodontal Research2005; 40(6), 474–481.

John Bissell, Sophiejoly, Georgia K.Johnson, Connie C. Organ, Deborah Dawson, Paul B. MC Cray, Janet M. Guthmiller.Expreesion of beta defensins in gingival health and in periodontal disease. Journal of oral pathology medicine 2004

Brancatisano F.L., Maisetta G.,Barsotti F.,Esin S., Miceli M., Gabriele M., Giuca M.R.,Campa M., and Batoni G. Reduced Human Beta defensin 3 in Individuals with Periodontal Disease. Journal of Dental Research 2011; 90(2):241-245.

Cheng-Che E. Lan, Ching-Shuang Wu, Shu-Mei Huang,Hsuan-Yu Kuo, I-Hui Wu,1 Chien-Hui Wen, Chee-Yin Chai, Ai-Hui Fang, and Gwo-Shing Chen. High-Glucose Environment Inhibits p38MAPK Signaling and Reduces Human β-3 Expression in Keratinocytes.Molecular Medicine 17(7-8)771-779.

Wings TY Loo, Lan-junBai, Chang-bin Fan,Yuan Yue, Yi-ding Dou, Min Wang.Clinical application of human β-defensin and CD14 gene polymorphism in evaluating the status of chronic inflammation

A. S. Ertugrul, A. Dikilitas, H. Sahin, N. Alpaslan, A. Bozoglan, Y. Tekin.Gingival crevicular fluid levels of human beta-defensins 1 and 3 in subjects with periodontitis and/or type 2 diabetes mellitus: a cross-sectional study. Journal of Periodontal Research 2012.

Jaganath S, Vijayendra R. Estimation of tumor necrosis factor-alpha in the gingival crevicular fluid of poorly, moderately and well controlled type 2 diabetes mellitus patients with periodontal disease-A Clinical and Biochemical study. Indian Journal of Stomatology. 2011 Jul 1;2(3):159.

Hosokawa I, Hosokawa Y, Komatsuzawa H, Goncalves RB, Karimbux N, Napimoga MH, Seki M, Ouhara K, Sugai M, Taubman MA, Kawai T. Innate immune peptide LL 37 displays distinct expression pattern from beta-defensins in inflamed gingival tissue. Clinical and Experimental Immunology 146:218–225

Ara Greer, Camille Zenobia & Richard P. Darvea.Defensins and LL-37: a review of unction in the gingival epithelium. Ueriodontology 2000 2013;63: 67–79.

Brancatisano FL, Maisetta G, Barsotti F. Reduced human beta defensin 3 in individuals with periodontal disease. Journal of Dental Research 2011;90:241–245.

. Dommisch H, Ac¸il Y, Dunsche A, Winter J, Jepsen S.Differential gene expression of humanb-defensins (hβD-1, -2, -3 in inflammatory gingival diseases. Oral Microbiology Immunology 2005: 20: 186–190.

Krisanaprakornkit S, Weinberg A, Perez CN, Dale BA.Expression of the peptide antibiotic human beta-defensin 1 in cultured gingival epithelial cells and gingival tissue. Infection and Immunulogy1998 ;66:4222–4228

Sawaki K, Mizukawa N, Yamaai T, Fukunaga J, Sugahara T. Immunohistochemical study on expression of alpha-defensin and beta-defensin-2 in human buccal epithelia with candidiasis. Oral Disease 2002;8:37–41

Kuula H, Salo T, Pirila E. Human beta-defensin-1 and -2 and matrix metalloproteinase25 and -26 expression in chronic and aggressive periodontitis and in peri-implantitis. Archives of Oral Biology 2008;53:175–186.

Maisetta G, Brancatisano FL, Esin S, Campa M, Batoni G. Gingipains produced by Porphyromonas gingivalis ATCC49417 degrade human-beta-defensin 3 and affect peptide’s antibacterial activity in vitro. Peptides 2011;32: 1073–1077.

KumariMinal, NaikSavitha B., ShanbhagNamita, A R Pradeep. Archives of Oral Sciences & Research2011; 1(4):221-227.

Lan CC, Wu CS, Huang SM, Kuo HY et al. High-Glucose Environment Inhibits p38MAPK Signaling and Reduces Human b-Defensin-3 Expression [corrected] in Keratinocytes. Mol Med 2011;17:771–779.

Plaschertogr, Grbic J. Levels of TNF-αin patients with chronic periodontits and type2 diabetes. Journal of clinical periodontology2007;34:18-24.

LLu Q, Samaranayake LP, Darveau RP, Jin L. Expression of human beta-defensin- 3 in gingival epithelia. Journal of Periodontal Research 2005;40:474–481

Al-Zahrani MS, Zawawi KH, Altaf FM. The effect of obesity and periodontitis on the expression of antimicrobial peptides in gingival tissues. Saudi Med J. 2013 May 1;34(5):525-30.

Mealey BL, Oates TW. Diabetes mellitus and periodontal diseases. Journal of Periodontology 2006;77:1289–1303

Mealey BL, Oates TW. Diabetes mellitus and periodontal diseases. Subgingival biodiversity in subjects with uncontrolled type-2 diabetes and chronic periodontitis. Journal of Periodontalogy Research 2012

Pereira AG, Costa LC, Soldati KR, De Abreu MH, Costa FO, Zandim-Barcelos DL, Cota LO. Gingival crevicular fluid levels of human beta-defensin 2 and 3 in healthy and diseased sites of individuals with and without periodontitis. J. Int. Acad. Periodontol. 2020 Jul 1;22:90-9.

Sulijaya B, Masulili SL, Auerkari EI. Human Beta-defensin-1 and Periodontal Disease: The Past, Present, and Future. Journal of Indonesian Dental Association. 2021 Apr 30;4(1):61-8.

Hemashree J, Dharman S. Evaluation of Malondialdehyde, Glutathione Peroxidase and Defensin Levels in Patients with and without Periodontitis. Indian Journal of Public Health Research & Development. 2020 Jan 1;11(1).

Hrishi, Thayyil Sivaraman, et al. "Comparative evaluation of GCF total antioxidant capacity in chronic periodontitis patients before and after non-surgical periodontal therapy." IJDRD 6 (2016): 11-6.

Kaul, Mehak, Sagrika Shukla, and Suresh Dk. "A Cursory Glance on Biomarkers for Bone in Health and Disease." International Journal of Dental Research & Development (IJDRD) 6 (2016): 49-58.

Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). Health and treatment of diabetes mellitus. International Journal of Health Sciences, 5(1), i-v. https://doi.org/10.53730/ijhs.v5n1.2864

Abbas, Hamed Jadooa, and Jawad Mohammad Ismail. "Association of Adiponectin Levels in Iraqi Patients With Type 2 Diabetic and Prediction of Cardiovascular Complications." TJPRC: International Journal of Diabetes & Research (TJPRC: IJDR) 2 (2016): 1-8.

SIVARANJANI, SS, et al. "Single Immediate Denture for a Diabetic Patient-A Case Report." International Journal of Dental Research & Development (IJDRD) 6.6 (2016) 17 22 (2016).

Ibrahim, Anwar Yonis, And Abdulkader Abdulwahab Al-Shakour. "Relationship Of Vitamin D Status With Insulin Resistance In Type 2 Diabetes Mellitus." International Journal of Medicine and Pharmaceutical Sciences (IJMPS) 6 (2016): 49-58.

Gunjigavi, Sanjeev Kumar S., T. Anil Kumar, and Ashwin Kulkarni. "Study Of Ischemic Heart Disease Among Patients With Asymptomatic Type-2 Diabetes Mellitus In A Tertiary Hospital In South India Using Computed Tomographic Angiography." International Journal of Medicine and Pharmaceutical Sciences (IJMPS) 10 (2020): 9-18.